IRIS Accounts Production v25.4.0.155 13693721 director 1.5.24 30.4.25 30.4.25 Medium entities residential care activities for the elderly and disabled. true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136937212024-04-30136937212025-04-30136937212024-05-012025-04-30136937212023-03-31136937212023-04-012024-04-30136937212024-04-3013693721ns15:EnglandWales2024-05-012025-04-3013693721ns14:PoundSterling2024-05-012025-04-3013693721ns10:Director12024-05-012025-04-3013693721ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3013693721ns10:MediumEntities2024-05-012025-04-3013693721ns10:Audited2024-05-012025-04-3013693721ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-05-012025-04-3013693721ns10:Medium-sizedCompaniesRegimeForAccounts2024-05-012025-04-3013693721ns10:FullAccounts2024-05-012025-04-301369372112024-05-012025-04-3013693721ns10:OrdinaryShareClass12024-05-012025-04-3013693721ns10:RegisteredOffice2024-05-012025-04-3013693721ns5:CurrentFinancialInstruments2025-04-3013693721ns5:CurrentFinancialInstruments2024-04-3013693721ns5:Non-currentFinancialInstruments2025-04-3013693721ns5:Non-currentFinancialInstruments2024-04-3013693721ns5:ShareCapital2025-04-3013693721ns5:ShareCapital2024-04-3013693721ns5:RetainedEarningsAccumulatedLosses2025-04-3013693721ns5:RetainedEarningsAccumulatedLosses2024-04-3013693721ns5:ShareCapital2023-03-3113693721ns5:RetainedEarningsAccumulatedLosses2023-03-3113693721ns5:RetainedEarningsAccumulatedLosses2023-04-012024-04-3013693721ns5:RetainedEarningsAccumulatedLosses2024-05-012025-04-3013693721ns5:NetGoodwill2024-05-012025-04-3013693721ns5:LongLeaseholdAssetsns5:LandBuildings2024-05-012025-04-3013693721ns5:PlantMachinery2024-05-012025-04-3013693721ns5:FurnitureFittings2024-05-012025-04-3013693721ns5:MotorVehicles2024-05-012025-04-3013693721ns15:UnitedKingdom2024-05-012025-04-3013693721ns15:UnitedKingdom2023-04-012024-04-3013693721ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-05-012025-04-3013693721ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-04-012024-04-3013693721ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-05-012025-04-3013693721ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-04-012024-04-3013693721ns5:OwnedAssets2024-05-012025-04-3013693721ns5:OwnedAssets2023-04-012024-04-3013693721ns5:NetGoodwill2023-04-012024-04-301369372132024-05-012025-04-301369372132023-04-012024-04-3013693721ns10:OrdinaryShareClass12023-04-012024-04-3013693721ns5:NetGoodwill2024-04-3013693721ns5:NetGoodwill2025-04-3013693721ns5:NetGoodwill2024-04-3013693721ns5:LongLeaseholdAssetsns5:LandBuildings2024-04-3013693721ns5:PlantMachinery2024-04-3013693721ns5:FurnitureFittings2024-04-3013693721ns5:MotorVehicles2024-04-3013693721ns5:LongLeaseholdAssetsns5:LandBuildings2025-04-3013693721ns5:PlantMachinery2025-04-3013693721ns5:FurnitureFittings2025-04-3013693721ns5:MotorVehicles2025-04-3013693721ns5:LongLeaseholdAssetsns5:LandBuildings2024-04-3013693721ns5:PlantMachinery2024-04-3013693721ns5:FurnitureFittings2024-04-3013693721ns5:MotorVehicles2024-04-3013693721ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-3013693721ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3013693721ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:FinanceLeases2025-04-3013693721ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:FinanceLeases2024-04-3013693721ns5:FinanceLeasesns5:BetweenOneFiveYears2025-04-3013693721ns5:FinanceLeasesns5:BetweenOneFiveYears2024-04-3013693721ns5:MoreThanFiveYearsns5:FinanceLeases2025-04-3013693721ns5:MoreThanFiveYearsns5:FinanceLeases2024-04-3013693721ns5:FinanceLeases2025-04-3013693721ns5:FinanceLeases2024-04-3013693721ns5:AcceleratedTaxDepreciationDeferredTax2025-04-3013693721ns5:AcceleratedTaxDepreciationDeferredTax2024-04-3013693721ns5:DeferredTaxation2024-04-3013693721ns5:DeferredTaxation2024-05-012025-04-3013693721ns5:DeferredTaxation2025-04-3013693721ns10:OrdinaryShareClass12025-04-301369372112024-05-012025-04-30
REGISTERED NUMBER: 13693721 (England and Wales)






























STRATEGIC REPORT,

REPORT OF THE DIRECTOR AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

FOR

WELFORD HEALTHCARE STH LIMITED

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025










Page

Company Information 1

Strategic Report 2

Report of the Director 4

Report of the Independent Auditors 5

Statement of Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 10

Notes to the Financial Statements 11


WELFORD HEALTHCARE STH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2025







DIRECTOR: Mr M P Madden



REGISTERED OFFICE: Granville Hall
Granville Road
Leicester
Leicestershire
LE1 7RU



REGISTERED NUMBER: 13693721 (England and Wales)



SENIOR STATUTORY AUDITOR: Mr P Bott FCA



AUDITORS: Mark J Rees LLP Chartered Accountants
and Statutory Auditors
Granville Hall
Granville Road
Leicester
LE1 7RU

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 APRIL 2025


The director presents his strategic report for the year ended 30 April 2025.

Welford Healthcare STH Limited runs two care homes Stanshawes Care Home and Westbury Care Home, which cater the needs of residents living with various levels of care requirements, including residential, respite, nursing, palliative and dementia care.

REVIEW OF BUSINESS
The Director is pleased with the strong results for the year which have been achieved in a challenging and strong market. Despite market pressures, occupancy has remained strong and fees increasingly competitive due to a focused sales strategy and ongoing contract negotiation with local authorities. Overall performance is greatly improved from prior year, this is largely due to the focus on sustainable sales, strong occupancy, and a stabilised workforce albeit with the impact of increasing workforce costs, as well as the full incorporation of the Westbury Care Home acquisition. Welford Healthcare STH Limited continue to seek opportunities for further growth through independent developments.

The company has continued to develop its working practices and governance to ensure homes meet Care Quality Commission (CQC) standards. Internal quality assurance monitoring accurately reflects the CQC inspection standard and the company is committed to working with the CQC to maintain the delivery of high quality care.

On 25 June 2024, Welford Healthcare STH Limited completed the purchase of the trading assets of Westbury Care Home. The results from this acquisition have been fully incorporated into the financial reporting for the year.

The results for the year and financial position of the company are as shown in the annexed financial statements.

Performance of the business and outlook

The prior year financial period covered 13 months, from 01 April 2023 to 30 April 2024, which is not directly comparable to current year's 12-month period. For comparative purposes, the prior year's income has been prorated to a 12-month period to allow for a more meaningful analysis of performance trends as detailed below.

Our KPI's, split by care home for the year, show the results for the year:

KPI's £   






2025



1 April 2023 to
30 April 2024
(13 month
period)
1 April 2023 to
30 April 2024
(Prorated 12
months)
Stanshawes Westbury Total Stanshawes Stanshawes
Turnover 3,167 1,976 5,143 2,908 2,684
Staff costs 1,510 1,158 2,668 1,399 1,291

The financial figures reported for Westbury Care Home reflect the period subsequent to its acquisition by Welford Healthcare STH Limited on 25 June 2024.

The company completes monthly management accounts, comparing these to budgets to measure actual performance.

The company's results are consolidated within Welford Healthcare CHH Limited, the ultimate parent company.

Our experienced management team and strong financial position enable us to be well positioned to continue the development of the company.


WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 APRIL 2025

PRINCIPAL RISKS AND UNCERTAINTIES
The principal risks for the company considered during the year ending 30 April 2025 are:

- Staff Recruitment - the ability to recruit and retain qualified carers and nurses is a continuing challenge for the whole sector. It impacts directly on the costs of operating care homes and the subsequent quality of care delivered.

- Home Occupancy - The company faces competition from other care providers in the regions in which it operates. If a home were to experience an increase in the volume of vacant rooms or the duration of vacancies, income streams and profitability of the care home can be impacted. The company manages occupancy levels continually and works to ensure relationships with local authorities and other commissioning bodies remain strong to ensure that room voids are filled as promptly as possible.

- Government Policy and Legislation Change - The company's operations are closely regulated by the Care Quality Commission (CQC). The consequences of non-compliance with regulations could be significant. The company has a robust system in place to ensure adherence to policies and compliance with regulatory requirements. Changes to CQC compliance are monitored to ensure policies and processes reflect any updates to ensure quality ratings are maintained. Risks also include those around health and safety compliance, legislative requirements and contractual risks.


ON BEHALF OF THE BOARD:





Mr M P Madden - Director


10 December 2025

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

REPORT OF THE DIRECTOR
FOR THE YEAR ENDED 30 APRIL 2025


The director presents his report with the financial statements of the company for the year ended 30 April 2025.

DIVIDENDS
An interim dividend of £830 per share was paid on 30 April 2025. The director recommends that no final dividend be paid.

The total distribution of dividends for the year ended 30 April 2025 will be £ 83,000 .

POST BALANCE SHEET EVENTS
Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTOR
Mr M P Madden held office during the whole of the period from 1 May 2024 to the date of this report.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Mark J Rees LLP Chartered Accountants, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mr M P Madden - Director


10 December 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
WELFORD HEALTHCARE STH LIMITED


Opinion
We have audited the financial statements of Welford Healthcare STH Limited (the 'company') for the year ended 30 April 2025 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 April 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
WELFORD HEALTHCARE STH LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page four, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities outlined above, to detect material misstatements in respect of irregularities, including fraud.

We have determined that the principal risk areas where material irregularities could occur were related to posting manual journal entries to manipulate financial performance, revenue recognition, significant one-off or unusual transaction, going concern and the CQC rating.

Our audit procedures were designed to respond in particular to these identified risks (including non compliance with laws and regulations and fraud).

Our audit procedures included but were not limited to:
- A review of a sample of occupancy reports in the year to ensure these were correctly recorded in revenue and detailed cut off testing around the year end to ensure revenue is correctly recognised.
- A review of laws and regulations the company is subject to, being specifically the CQC review and rating and discussion with management to ensure no instances of non compliance.
- Addressing the risks of fraud through management override of controls by performing journal entry testing.
- A review of the going concern of the company through an inspection of the after date position, consideration of group support and a review of management's going concern risk assessment.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
WELFORD HEALTHCARE STH LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Mr P Bott FCA (Senior Statutory Auditor)
for and on behalf of Mark J Rees LLP Chartered Accountants
and Statutory Auditors
Granville Hall
Granville Road
Leicester
LE1 7RU

11 December 2025

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 APRIL 2025

Period
1.4.23
Year Ended to
30.4.25 30.4.24
Notes £    £   

TURNOVER 3 5,143,857 2,908,660

Cost of sales 2,730,488 1,375,329
GROSS PROFIT 2,413,369 1,533,331

Administrative expenses 1,561,188 973,298
OPERATING PROFIT 5 852,181 560,033


Interest payable and similar expenses 6 541,777 223,176
PROFIT BEFORE TAXATION 310,404 336,857

Tax on profit 7 121,782 94,353
PROFIT FOR THE FINANCIAL YEAR 188,622 242,504

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

188,622

242,504

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

BALANCE SHEET
30 APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 102,493 25,127
Tangible assets 10 9,197,803 3,627,988
9,300,296 3,653,115

CURRENT ASSETS
Debtors 11 1,419,128 1,536,678
Cash at bank and in hand 161,546 286,503
1,580,674 1,823,181
CREDITORS
Amounts falling due within one year 12 797,755 1,307,177
NET CURRENT ASSETS 782,919 516,004
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,083,215

4,169,119

CREDITORS
Amounts falling due after more than one
year

13

(9,281,610

)

(3,606,791

)

PROVISIONS FOR LIABILITIES 15 (51,232 ) (17,705 )
NET ASSETS 750,373 544,623

CAPITAL AND RESERVES
Called up share capital 16 100 100
Retained earnings 750,273 544,523
SHAREHOLDERS' FUNDS 750,373 544,623

The financial statements were approved by the director and authorised for issue on 10 December 2025 and were signed by:





Mr M P Madden - Director


WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 April 2023 100 302,019 302,119

Changes in equity
Total comprehensive income - 242,504 242,504
Balance at 30 April 2024 100 544,523 544,623

Changes in equity
Dividends - (83,000 ) (83,000 )
Total comprehensive income - 288,750 288,750
Balance at 30 April 2025 100 750,273 750,373

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025


1. STATUTORY INFORMATION

Welford Healthcare STH Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Comparative Figures
The comparative figures are for 13 month period of trading to 30 April 2024.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Turnover
Turnover is measured at the fair value of the consideration received or receivable excluding discounts and rebates.

Turnover represents income receivable from health and care provision services rendered and goods supplied.

Turnover is recognised in the accounting period in which the company obtains the right to consideration in exchange for its performance.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of the two businesses, is being amortised evenly over its estimated useful life of five years.

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - equal instalments over the lease period
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Motor vehicles - over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Leases
Assets held under finance leases which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or if lower, the present value of the minimum lease payments as determined at the inception of the lease and are depreciated over the shorter of the lease terms and their useful lives).The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the profit and loss account over the period of the lease to produce a constant periodic rate of interest on the remaining balance of the liability.

Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate, including changes in market rental rates following a market rent review, or, as appropriate, changes in the assessment of whether a renewal or purchase option is reasonably certain to be exercised or a break clause is reasonably certain not to be exercised. The revised lease payments are discounted using the company’s incremental borrowing rate at the lease commencement date when the rate implicit in the lease cannot be readily determined. The amount of the remeasurement of the lease liability is reflected as an adjustment to the carrying amount of the long leasehold asset. The exception being when the carrying amount of the right-of-use asset has been reduced to zero then any excess is recognised in the income statement.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


2. ACCOUNTING POLICIES - continued

Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently, where material, at amortised cost using the effective interest method, less any impairment.

Creditors
Short term creditors are measured at transaction price, less any impairment. Other financial liabilities, including bank loans are measured initially at fair value, net of transaction costs, and are measured subsequently, where material, at amortised cost using the effective interest method, less any impairment.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
United Kingdom 5,143,857 2,908,660
5,143,857 2,908,660

4. EMPLOYEES AND DIRECTORS
Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Wages and salaries 2,412,375 1,268,605
Social security costs 207,242 105,361
Other pension costs 48,445 25,063
2,668,062 1,399,029

The average number of employees during the year was as follows:
Period
1.4.23
Year Ended to
30.4.25 30.4.24

Administration 3 2
Care 116 54
119 56

During the year, remuneration of £154,768 (2024:122,985) was paid to key management personnel.

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


4. EMPLOYEES AND DIRECTORS - continued

Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Director's remuneration - -

5. OPERATING PROFIT

The operating profit is stated after charging:

Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Hire of plant and machinery 1,272 -
Depreciation - owned assets 317,001 222,944
Goodwill amortisation 24,886 6,375
Auditors remuneration 20,580 12,740

6. INTEREST PAYABLE AND SIMILAR EXPENSES
Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Other interest 541,777 223,176

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Current tax:
UK corporation tax 88,255 90,336

Deferred taxation 33,527 4,017
Tax on profit 121,782 94,353

UK corporation tax has been charged at 25% (2024 - 25%).

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Profit before tax 310,404 336,857
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

77,601

84,214

Effects of:
Expenses not deductible for tax purposes (24,810 ) 65,004
Capital allowances in excess of depreciation - (54,865 )
Depreciation in excess of capital allowances 68,991 -
Total tax charge 121,782 94,353

8. DIVIDENDS
Period
1.4.23
Year Ended to
30.4.25 30.4.24
£    £   
Ordinary shares of £1 each
Interim 83,000 -

9. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2024 37,877
Additions 102,252
At 30 April 2025 140,129
AMORTISATION
At 1 May 2024 12,750
Amortisation for year 24,886
At 30 April 2025 37,636
NET BOOK VALUE
At 30 April 2025 102,493
At 30 April 2024 25,127

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


10. TANGIBLE FIXED ASSETS
Fixtures
Long Plant and and Motor
leasehold machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 May 2024 3,918,500 29,784 87,799 23,649 4,059,732
Additions 5,784,813 65,924 36,079 - 5,886,816
At 30 April 2025 9,703,313 95,708 123,878 23,649 9,946,548
DEPRECIATION
At 1 May 2024 388,912 5,345 29,604 7,883 431,744
Charge for year 279,614 8,732 20,772 7,883 317,001
At 30 April 2025 668,526 14,077 50,376 15,766 748,745
NET BOOK VALUE
At 30 April 2025 9,034,787 81,631 73,502 7,883 9,197,803
At 30 April 2024 3,529,588 24,439 58,195 15,766 3,627,988

The remeasurement of the lease liability has been recognised as a result of a change in lease payments. This adjustment has been capitalised as an addition to the carrying amount of the long leasehold asset in the period.

Furthermore, a new long leasehold asset has been capitalised during the period relating to Westbury Care Home.

11. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 299,585 252,626
Bad debt provision (67,125 ) 14,902
Amounts owed by group undertakings 1,071,464 397,100
Other debtors 25,570 776,220
Taxation 64,667 -
Prepayments and accrued income 24,967 95,830
1,419,128 1,536,678

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Finance leases (see note 14) 116,340 105,586
Trade creditors 174,417 163,383
Amounts owed to group undertakings 356 -
Taxation - 43,340
Paye/Ni payable - 38,227
Other creditors 141,683 884,993
Accruals and deferred income 364,959 71,648
797,755 1,307,177

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Finance leases (see note 14) 9,281,610 3,606,791

14. LEASING AGREEMENTS

Minimum lease payments under finance leases fall due as follows:

Finance leases
2025 2024
£    £   
Net obligations repayable:
Within one year 116,340 105,586
Between one and five years 546,162 485,357
In more than five years 8,735,448 3,121,434
9,397,950 3,712,377

15. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 51,232 17,705

Deferred
tax
£   
Balance at 1 May 2024 17,705
Provided during year 33,527
Balance at 30 April 2025 51,232

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100

17. PENSION COMMITMENTS

The company operates defined contribution pension schemes. The assets of the schemes are held separately from those of the company within independently administered funds. The total contributions paid in the period amounted to £48,445 (2024: £25,063). Contributions of £2,537 (2024: £6,595) were unpaid at the year end.

WELFORD HEALTHCARE STH LIMITED (REGISTERED NUMBER: 13693721)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025


18. RELATED PARTY DISCLOSURES

At 30 April 2025 the company was owed £92,669 (2024: £785,114) by related parties and owed £18,665 (2024: £776,219) to related parties.

All of the related party companies share the same director.

19. POST BALANCE SHEET EVENTS

On 24 July 2025, the company completed the trade and assets purchase of a new care home, Oake Meadows Care Home.

20. ULTIMATE CONTROLLING PARTY

The parent and ultimate controlling parent company at the balance sheet date is Welford Healthcare ChH Limited, a private limited company incorporated and registered in England and Wales. The registered office of Welford Healthcare ChH Limited is Granville Hall, Granville Road, Leicester, LE1 7RU and copies of the parents financial statements are available from Companies House, Crown Way, Cardiff, CF14 3UZ.